Polymer nanomedicines (macromolecular therapeutics, polymer-drug conjugates, drug-free
macromolecular therapeutics) are a group of biologically active compounds that are …

This overview focuses on bioconjugates of water-soluble polymers with low molecular
weight drugs and proteins. After a short discussion of the origins of the field, the state-of-the …

This review covers water-soluble polymer–drug conjugates and macromolecules that
possess biological activity without attached low molecular weight drugs. The main design …

Interdisciplinary research at the interface of polymer chemistry and the biomedical sciences
has produced the first polymer-based nanomedicines for the diagnosis and treatment of …

Polymer Therapeutics have enormously evolved in the past decades. Several polymeric
drugs as well as polymer–protein conjugates have been in the market since the 90s, but …

The state-of-the art in water-soluble macromolecular therapeutics has been reviewed. First
the design principles for polymer-drug conjugates are discussed followed by two recent …

Polymer–drug conjugates have long been a mainstay of the drug delivery field, with several
conjugates successfully translated into clinical practice. The conjugation of therapeutic …

The majority of anti-cancer drugs show poor water solubility and produce adverse effects in
healthy tissue. The combination of polymer technology and targeted drug delivery system …

Polymers play important roles in the design of delivery nanocarriers for cancer therapies.
Polymeric nanocarriers with anticancer drugs conjugated or encapsulated, also known as …

The combination of polymer technology and targeted drug delivery may pave the way for
more effective yet safer therapeutic options for cancer therapy. Polymer-drug conjugates …